NOT MEDICAL ADVICE. No information on this site should be considered medical advice. Research peptides are not intended for human consumption — in-vitro lab use only. Consult a physician prior to introducing anything into the human body.
Peptide HubResearch Peptide Wiki
Support Us Join

Home/Skin, Hair & Cosmetic/GLOW (GHK-Cu / BPC-157 / TB-500 Blend)

GLOW (GHK-Cu / BPC-157 / TB-500 Blend)

Supplier-formulated three-peptide combination (GHK-Cu, BPC-157, TB-500) with no published studies of the blend itself.

Overview

GLOW is a commercial name for a combination product sold by research-supply vendors, described in the listing as a blend of GHK-Cu, BPC-157, and TB-500 in a single vial. No peer-reviewed study has evaluated this three-peptide mixture as such; the name, ratio, and presentation are defined by the individual supplier. Each component is independently characterized in the literature and covered by its own entry: GHK-Cu (copper tripeptide, skin remodeling), BPC-157 (synthetic pentadecapeptide studied in animal models of tissue healing), and TB-500 (a supplier name for a thymosin beta-4 based product).

Mechanism

No published mechanistic work exists on the combination itself. The formulation rationale, as described by vendors, is to combine three peptides with complementary tissue-repair research profiles: extracellular-matrix remodeling (GHK-Cu), gastrointestinal and soft-tissue healing signals (BPC-157), and actin-mediated cell migration relevant to wound repair (TB-500 / thymosin beta-4).

Expected Effects

No peer-reviewed data support effects of the blend as a whole; any expected profile is extrapolated from the component literature and from vendor descriptions, not from studies of GLOW itself.

Side Effects & Tolerability

Because the blend lacks independent safety data, its tolerability cannot be characterized. Potential reactions should be inferred from the individual components, such as nausea reported with injectable GHK-Cu and injection-site reactions, plus the general contamination and consistency risks of unregulated multi-peptide vials.

Storage

The lyophilized blend should be stored frozen and desiccated per the supplier label. Note that multi-peptide formulations raise additional stability questions, because each component has its own optimal storage and reconstitution conditions; solutions should be used promptly and never refrozen after reconstitution.

Related peptides

Argireline (Acetyl Hexapeptide)Trade name of a synthetic acetyl hexapeptide used as a topical cosmetic anti-wrinkle ingredient; effects are modest and limited to cosmetic formulations.Biotin-GHK (Biotinylated Peptides)Cosmetic-ingredient peptides combining biotin with the GHK tripeptide (e.g., biotinoyl tripeptide-1); published data on these forms are very limited.Collagen Remodeling Peptide AnalogsVendor grouping of peptides marketed for skin collagen remodeling; product identities are undisclosed.Defensin Skin Barrier AnalogsCatalog category implying defensin-type peptides for skin-barrier and microbiome support; products are not defined in the literature.Dermal Stem Cell Activator AnalogsMarketing-style name implying peptides that activate dermal stem cells; no specific compounds are described in the literature.Matrixyl (Palmitoyl Pentapeptide)Trade name for palmitoyl pentapeptide-4, a cosmetic peptide used in topical formulations for its collagen-related signaling activity.